Assyro AI

FDA Orange Book · active-ingredient family

Doxapram hydrochloride

Doxapram hydrochloride is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DOPRAM · NDA 014879

1

Brand (NDA)

2

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
DOPRAMRLDHIKMANDA 014879APApproved Prior to Jan 1, 1982

Generic (ANDA) products (2)

ProductApplicantApplicationTEApproved
DOXAPRAM HYDROCHLORIDECHARTWELL INJECTABLEANDA 076266APJan 10, 2003
DOXAPRAM HYDROCHLORIDEWATSON LABSANDA 073529Jan 30, 1992

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Doxapram hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.